Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Mink Intersects 7.1 Meters of 0.44% Ni, 0.28% Cu, 0.06% Co in Massive Sulphide at Warren Property (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Endonovo Therapeutics Inc (ID) ENDV

Healthcare Biotechnology
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also... see more

Recent & Breaking News ()

Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc

GlobeNewswire March 28, 2024

Endonovo's SofPulse® to Be Featured at Innovative Pain Management Solutions

GlobeNewswire March 4, 2024

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

GlobeNewswire December 4, 2023

Endonovo's SofPulse® Secures Taiwan FDA Approval

GlobeNewswire October 12, 2023

Endonovo's SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

GlobeNewswire August 22, 2023

Endonovo's Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

GlobeNewswire August 8, 2023

Endonovo Pending Agreement to Develop Telehealth Division

GlobeNewswire June 7, 2023

Endonovo Launches SofPulse® into the Veterans Administration

GlobeNewswire May 2, 2023

Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies

GlobeNewswire April 25, 2023

Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman

GlobeNewswire April 13, 2023

Endonovo Announces Partnership with Santana Lead Singer Andy Vargas

GlobeNewswire April 10, 2023

Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company

GlobeNewswire March 29, 2023

Endonovo's SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan

GlobeNewswire March 23, 2023

Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery 

GlobeNewswire March 15, 2023

Endonovo Announces Distribution Agreement with Academy Medical

GlobeNewswire March 6, 2023

Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg

GlobeNewswire February 28, 2023

Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off

GlobeNewswire January 31, 2023

Endonovo Partners with International Distributor for SofPulse® Line

GlobeNewswire January 26, 2023

New Details on Endonovo's Spin-Off of SofPulse, Inc.

GlobeNewswire January 19, 2023

Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company

GlobeNewswire January 9, 2023

Podcasts